ANDA 74545, held by Luitpold. Dobutamine Hydrochloride.
As of Nov 16, 2026, ANDA 74545 (Dobutamine Hydrochloride), held by Luitpold, was first approved by FDA on Jun 25, 1998, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 25, 1998 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Dobutamine HydrochlorideEQ 12.5MG BASE/ML ยท injectable;injection | Dobutamine Hydrochloride | Discontinued |
| Jan 30, 2002 | Supplement 1Labeling | Approved | None posted |
| Jun 25, 1998 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters